Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia

Matteo Marchetti, Stefano Barelli, Maxime G. Zermatten, Fanny Monnin-Respen, Elena Matthey-Guirao, Nicole Nicolas, Francisco Gomez, Matthew Goodyer, Christiane Gerschheimer, Lorenzo Alberio

Blood (2020) 135 (14): 1171–1184.

https://doi.org/10.1182/blood.2019002845

Published: 2020

Includes: Supplemental data

Journal Articles

Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing

James B Smadbeck, Beth A Pitel, MA, Kathryn E. Pearce, Sarah H Johnson, MS, Nicole Hoppman, Rhett P. Ketterling, MD, Patricia Griepp, MD, Linda B Baughn, PhD, George Vasmatzis, PhD, Jess Peterson, MD

Blood (2019) 134 (Supplement_1): 5212.

https://doi.org/10.1182/blood-2019-122440

Published: 2019

Journal Articles

Comparison of Three Assays for Identification of IDH Mutations in AML

Sara Ribeiro, BSc, Dorte Wren, PhDFRCPath, Lisa Thompson, PhD MSc, FIBMS, Michael Hubank, PhD, David Taussig, PhD MRCP, FRCPath

Blood (2019) 134 (Supplement_1): 5195.

https://doi.org/10.1182/blood-2019-126494

Published: 2019

Journal Articles

Implementing a Specialist Integrated Haematological Malignancy Imaging Reporting Paradigm to Lymphoma Radiology Assessment Can Significantly Improve the Quality of Data for Patient Management and Clinical Research

Preethika Mahalingam, MBBS, BSc, Sunil Iyengar, MBBS, FRCPath, PhD, Dima El-Sharkawi, Bhupinder Sharma, MBBS, BSc(Hons) BM FRCR

Blood (2019) 134 (Supplement_1): 5835.

https://doi.org/10.1182/blood-2019-126155

Published: 2019

Journal Articles

Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)

Blood (2019) 134 (Supplement_1): 69.

https://doi.org/10.1182/blood-2019-129499

Published: 2019

Journal Articles

An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL)

DR. Brian Koffman, John M. Pagel, MD PhD DSc, Andy Kaempf, Byung Park, PhD, Liza Avruch, Christopher Lee, PhD MS, Babak Movassaghi, PhD MBA, John C. Byrd, MD, Alan Skarbnik, MD, Matthew S. Davids, MD, Alexey Danilov, MD PhD

Blood (2019) 134 (Supplement_1): 4716.

https://doi.org/10.1182/blood-2019-123579

Published: 2019

Journal Articles

Extracellular Vesicles: Overview and Clinical Implications

Francoise Dignat-George

Blood (2018) 132 (Supplement 1): SCI-25.

https://doi.org/10.1182/blood-2018-99-109472

Published: 2018

Journal Articles

Impact of Mhealth and Ehealth Applications on Hemophilia Treatment Management

Maria Margalida Santandreu Estelrich, MD, José María Sánchez-Raga, MD, Antonio Palomero Massanet, Bernat Galmés Sureda, Olga Delgado, MD, Antonia Sampol, MD PhD, Mariana Canaro, PhD MD

Blood (2018) 132 (Supplement 1): 5038.

https://doi.org/10.1182/blood-2018-99-119139

Published: 2018

Journal Articles

Epidemiology of Mylofibrosis from Three Different French Area Covered By a Population-Based Registry

Marc Maynadie, MD PhD, Sophie Gauthier, Morgane Mounier, Edouard Cornet, MD, Sandra Le Guyader, PhD, Jean Marc Poncet, Hélène Rachou, Alain Monnereau, MD PhD, Xavier Troussard, MD

Blood (2018) 132 (Supplement 1): 5467.

https://doi.org/10.1182/blood-2018-99-112927

Published: 2018

Journal Articles

Confirmation of the Utility of the 4T Scoring System for HIT

Zachary Trisel, MD, Mark Maddox, DO, Ahmed Safa, MD, Thomas Bemis, MD, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 5816.

https://doi.org/10.1182/blood-2018-99-119573

Published: 2018

Journal Articles

Econsultation to Hematologists from Primary Care: An Assessment of Content and Patient Impact

Megan Leslie, BS, Sa Ra Park, MD, Jennifer Wang, MD, Kelly Mercer Davidson, MD, Kimberly Dowdell, MD

Blood (2018) 132 (Supplement 1): 2279.

https://doi.org/10.1182/blood-2018-99-114149

Published: 2018

Journal Articles

Computational Modeling of Protein Networks Predicts Treatment Outcomes in Multiple Myeloma (MM)

Leylah M. Drusbosky, PhD, Hemant S. Murthy, MD, Helen L. Leather, Himanshu Grover, MS, Yugandhara Narvekar, MS, Pallavi Kumari, MS, Sirisha Narayanabhatia, MS, Priyanka Bhowmick, MS, Taher Abbasi, MS, MBA, Shireen Vali, PhD, Qing Zhang, PhD, Saad Z Usmani, MD, Christopher R. Cogle, MD

Blood (2017) 130 (Supplement 1): 592.

https://doi.org/10.1182/blood.V130.Suppl_1.592.592

Published: 2017

Journal Articles

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management

Ilaria Chicca, PhD, Jennifer LJ Heaney, PhD, Gulnaz Iqbal, PhD, Stella Bowcock, MDMA, Tim Planche, MDPhD, Jill Wood, MPH, Kerry Raynes, MSc, Peter Hawkey, FRCPath, Guy Pratt, MD FRCP, FRCPath, Kwee Yong, PhD, Helen Higgins, MSc, Janet Dunn, PhD, Mark T Drayson, MD PhD

Blood (2017) 130 (Supplement 1): 3036.

https://doi.org/10.1182/blood.V130.Suppl_1.3036.3036

Published: 2017

Journal Articles

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Fabio Efficace, Gianluca Gaidano, Francesco Lo-Coco

Blood (2017) 130 (7): 859–866.

https://doi.org/10.1182/blood-2017-03-737403

Published: 2017

Journal Articles

Title: Progression-Free Survival 2 in Hematological Cancer Treatment Choices: Challenges to Routine Use

Angela Solaman, MHEcon, Andrew Walker, PhD, Faith E Davies, MD

Blood (2016) 128 (22): 5982.

https://doi.org/10.1182/blood.V128.22.5982.5982

Published: 2016

Journal Articles

The role of hematologists in a changing United States health care system

Paul J. Wallace, Nathan T. Connell, Janis L. Abkowitz

Blood (2015) 125 (16): 2467–2470.

https://doi.org/10.1182/blood-2014-12-615047

Published: 2015

Journal Articles

Treatment and Management of Chronic Myelogenous Leukemia in Patients Cared for in a Large HMO

Reina Haque, PhD MPH, Jiaxiao Shi, PhD, Joanie Chung, MPH, Chantal C Avila, MA, Lei Chen, MD PhD, Joanne E Schottinger, MD

Blood (2014) 124 (21): 1310.

https://doi.org/10.1182/blood.V124.21.1310.1310

Published: 2014

Journal Articles

Changes in Diagnoses and Outcomes for Patients of Hematopathology Specialty and Other Laboratories

Nicole M. Engel-Nitz, Ph.D., Benjamin Eckert, MS, Rui Song, PhD, Erin M. Hulbert, MS, Jeffrey McPheeters, April Teitelbaum, MD, MS, FACP

Blood (2012) 120 (21): 4700.

https://doi.org/10.1182/blood.V120.21.4700.4700

Published: 2012

Journal Articles

Early Discharge and Out Patient Management After AML Induction Chemotherapy: Determinants of Safety

Roberto A Ferro, MD, Junjia Zhu, Ph.D, W. Christopher Ehmann, MD, Susan Rokita, CRNP, MSN, Vicki Haight, CRNP, MSN, Jo Ann Davidson, CRNP, MSN, Constance Berk, PA-C, Witold Rybka, MD, David F. Claxton, MD

Blood (2012) 120 (21): 2054.

https://doi.org/10.1182/blood.V120.21.2054.2054

Published: 2012

Journal Articles

Increased Cytogenetic Testing and Prognostic Assessment Do Not Translate Into Higher Active Treatment of Elderly MDS Patients in Germany

Norbert Gattermann, MD, Andrea Kuendgen, MD, Lenka Kellermann, BS, MBA, Matti Zeffel, BS, Bernadette Paessens, PhD, Ulrich Germing, MD

Blood (2011) 118 (21): 510.

https://doi.org/10.1182/blood.V118.21.510.510

Published: 2011

NARROW

Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia

Differentiating between Hyperdiploidy and Pseudo-Hyperdiploidy in B-Lymphoblastic Leukemia Utilizing Low-Coverage Mate-Pair Sequencing

Comparison of Three Assays for Identification of IDH Mutations in AML

Implementing a Specialist Integrated Haematological Malignancy Imaging Reporting Paradigm to Lymphoma Radiology Assessment Can Significantly Improve the Quality of Data for Patient Management and Clinical Research

Vulnerable Elders Survey-13 (VES-13) Predicts 1-Year Mortality Risk in Newly Diagnosed Non-Hodgkin Lymphoma (NHL)

An Innovative Telemedicine Platform to Provide Expert Access to Patients with Chronic Lymphocytic Leukemia (CLL)

Extracellular Vesicles: Overview and Clinical Implications

Impact of Mhealth and Ehealth Applications on Hemophilia Treatment Management

Epidemiology of Mylofibrosis from Three Different French Area Covered By a Population-Based Registry

Confirmation of the Utility of the 4T Scoring System for HIT

Econsultation to Hematologists from Primary Care: An Assessment of Content and Patient Impact

Computational Modeling of Protein Networks Predicts Treatment Outcomes in Multiple Myeloma (MM)

Assessment of Anti-Bacterial Antibodies in Multiple Myeloma Patients at Disease Presentation and in Response to Therapy: Implication for Patient Management

Patient-reported outcomes in hematology: is it time to focus more on them in clinical trials and hematology practice?

Title: Progression-Free Survival 2 in Hematological Cancer Treatment Choices: Challenges to Routine Use

The role of hematologists in a changing United States health care system

Treatment and Management of Chronic Myelogenous Leukemia in Patients Cared for in a Large HMO

Changes in Diagnoses and Outcomes for Patients of Hematopathology Specialty and Other Laboratories

Early Discharge and Out Patient Management After AML Induction Chemotherapy: Determinants of Safety

Increased Cytogenetic Testing and Prognostic Assessment Do Not Translate Into Higher Active Treatment of Elderly MDS Patients in Germany

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only